These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention. Chavez-de la Paz E; Arevalo JF; Kirsch LS; Munguia D; Rahhal FM; De Clercq E; Freeman WR Ophthalmology; 1997 Mar; 104(3):539-44. PubMed ID: 9082286 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis. Rahhal FM; Arevalo JF; Munguia D; Taskintuna I; Chavez de la Paz E; Azen SP; Freeman WR Ophthalmology; 1996 Jul; 103(7):1078-83. PubMed ID: 8684797 [TBL] [Abstract][Full Text] [Related]
6. Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Kirsch LS; Arevalo JF; De Clercq E; Chavez de la Paz E; Munguia D; Garcia R; Freeman WR Am J Ophthalmol; 1995 Apr; 119(4):466-76. PubMed ID: 7709971 [TBL] [Abstract][Full Text] [Related]
7. Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report. Rahhal FM; Arevalo JF; Chavez de la Paz E; Munguia D; Azen SP; Freeman WR Ann Intern Med; 1996 Jul; 125(2):98-103. PubMed ID: 8678386 [TBL] [Abstract][Full Text] [Related]
8. Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Davis JL; Taskintuna I; Freeman WR; Weinberg DV; Feuer WJ; Leonard RE Arch Ophthalmol; 1997 Jun; 115(6):733-7. PubMed ID: 9194724 [TBL] [Abstract][Full Text] [Related]
9. Ocular side-effects from systemic HPMPC (Cidofovir) for a non-ocular cytomegalovirus infection. Scott RA; Pavesio C Am J Ophthalmol; 2000 Jul; 130(1):126-7. PubMed ID: 11004276 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal and plasma cidofovir concentrations after intravitreal and intravenous administration in AIDS patients with cytomegalovirus retinitis. Taskintuna I; Rahhal FM; Capparelli EV; Cundy KC; Freeman WR J Ocul Pharmacol Ther; 1998 Apr; 14(2):147-51. PubMed ID: 9572540 [TBL] [Abstract][Full Text] [Related]
12. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis. Akler ME; Johnson DW; Burman WJ; Johnson SC Ophthalmology; 1998 Apr; 105(4):651-7. PubMed ID: 9544639 [TBL] [Abstract][Full Text] [Related]
13. Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis. Accorinti M; Ciapparoni V; Pirraglia MP; Pivetti-Pezzi P Ocul Immunol Inflamm; 2001 Sep; 9(3):211-7. PubMed ID: 11815890 [TBL] [Abstract][Full Text] [Related]
14. Hypotony after intravenous cidofovir therapy for the treatment of cytomegalovirus retinitis. Wang L; Damji KF; Chialant D; Hodge WG Can J Ophthalmol; 2002 Dec; 37(7):419-22. PubMed ID: 12516724 [No Abstract] [Full Text] [Related]
15. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects. Taskintuna I; Banker AS; Rao NA; Wiley CA; Flores-Aguilar M; Munguia D; Bergeron-Lynn G; De Clercq E; Keefe K; Freeman WR Exp Eye Res; 1997 May; 64(5):795-806. PubMed ID: 9245910 [TBL] [Abstract][Full Text] [Related]
16. Uveitis in patients treated with intravenous cidofovir. Cochereau I; Doan S; Diraison MC; Mousalatti H; Guvenisik N; Ren L; Hoang-Xuan T Ocul Immunol Inflamm; 1999 Dec; 7(3-4):223-9. PubMed ID: 10611731 [TBL] [Abstract][Full Text] [Related]
18. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits. Cundy KC; Lynch G; Shaw JP; Hitchcock MJ; Lee WA Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758 [TBL] [Abstract][Full Text] [Related]
19. Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis. Friedberg DN Arch Ophthalmol; 1997 Jun; 115(6):801-2. PubMed ID: 9194736 [No Abstract] [Full Text] [Related]
20. [Ocular complications after treatment with intravenous cidofovir for cytomegalovirus retinitis]. Martínez de la Casa JM; Matilla Rodero M; Castillo A; García Feijoó J; García Sánchez J Arch Soc Esp Oftalmol; 2001 Apr; 76(4):213-20. PubMed ID: 11340511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]